Latest Safety News

Aeris Resources reported steady Q1 FY26 production with 10.3kt copper equivalent at AISC of A$4.64/lb, alongside significant growth capital investment and promising exploration results.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

Volt Resources has reached a key technical milestone by consistently producing ultra-high purity graphite using a proprietary, hydrofluoric acid-free process, paving the way for U.S.-based battery-grade graphite production.

Island Pharmaceuticals secures FDA confirmation that regulatory feedback on Galidesivir’s approval pathway will arrive on schedule, underscoring the drug’s strategic importance amid US government disruptions.

Renascor Resources reports steady progress on its Purified Spherical Graphite demonstration plant in Adelaide, backed by a $5 million government grant, aiming to challenge China’s dominance in battery materials.

Codan Limited reported a strong FY25 with significant revenue and profit growth, bolstered by a key U.S. acquisition and a robust outlook for FY26 driven by defense spending and gold market strength.

SSH Group has landed a $2.53 million strategic placement from Hong Kong Xinhai Mining Services, marking a pivotal step in its evolution into a vertically integrated mining powerhouse.

Service Stream has delivered a robust FY25 performance with revenue growth, record profits, and a landmark $1.6 billion Defence contract, setting the stage for continued expansion.

Evergreen Lithium has secured key regulatory approvals to begin reverse circulation drilling at its Mt Monger Gold Project, targeting high-potential gold prospects Duchess of York and Kiaki Soaks. The campaign aims to unlock valuable insights and guide further exploration in 2026.

BPM Minerals has secured the Forelands Gold Project with promising high-grade intercepts and divested its Claw Gold Project to Capricorn Metals, bolstering its cash position ahead of upcoming drilling.

Ora Banda Mining Ltd reported a record September quarter with a 39% surge in gold production and a 37% rise in gold sales, underpinned by strong operational performance and exploration success.

Nyrada has completed its Phase I trial for Xolatryp, confirming safety and predictable pharmacokinetics, while securing AU$8.25 million to fund an upcoming Phase IIa trial targeting heart attack patients.